THE STUDIES
While there is hope that the worst of the pandemic is behind us, hundreds of thousands of new cases of COVID-19 are still reported daily around the globe. That is why it’s so important to continue to advance not only prevention, but also treatment of COVID-19. These clinical trials are evaluating whether an oral study drug reduces the duration and/or severity of illness among people with COVID-19 or prevents the onset of COVID-19 symptoms in household members.

COVID-19 – RECENTLY DIAGNOSED OR SYMPTOMATIC CHILDREN AND TEENS AT INCREASED RISK OF SEVERE ILLNESS
For children and teens ages 6 – 17 who have COVID-19 symptoms or have recently tested positive for COVID-19, and have health conditions that put them at risk for severe illness. Now Enrolling.
Learn More
COVID-19 – RECENTLY DIAGNOSED PATIENTS AT INCREASED RISK OF WORSENING SYMPTOMS
For those 18 years of age and older who have COVID-19 symptoms, as well as health conditions that put them at high risk for severe illness. No Longer Enrolling.
Learn More
COVID-19 – FOR HOUSEHOLD MEMBERS OF THOSE RECENTLY DIAGNOSED
For adults living in the same home as individuals with diagnosed, symptomatic COVID-19. No Longer Enrolling.
Learn More
COVID-19 – RECENTLY DIAGNOSED PATIENTS
For those 18 years of age and older who have COVID-19 symptoms and have tested positive for COVID-19 within the last 5 days, but do not have any health conditions putting them at risk for severe illness, or have these conditions but are fully vaccinated. No Longer Enrolling.